INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
USA - NYSE:INSP - US4577301090 - Common Stock
77.52 USD
-2.65 (-3.31%)
78.95 USD
+1.43 (+1.84%)
We assign a fundamental rating of 6 out of 10 to INSP. INSP was compared to 190 industry peers in the Health Care Equipment & Supplies industry. INSP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INSP is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make INSP a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
In the past year INSP was profitable.
INSP had a positive operating cash flow in the past year.
In the past 5 years INSP reported 4 times negative net income.
In multiple years INSP reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.62%, INSP belongs to the top of the industry, outperforming 86.84% of the companies in the same industry.
The Return On Equity of INSP (7.84%) is better than 81.05% of its industry peers.
The Return On Invested Capital of INSP (5.35%) is better than 77.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.62% | ||
| ROE | 7.84% | ||
| ROIC | 5.35% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 6.17%, INSP is doing good in the industry, outperforming 77.37% of the companies in the same industry.
With a decent Operating Margin value of 4.81%, INSP is doing good in the industry, outperforming 69.47% of the companies in the same industry.
INSP has a Gross Margin of 84.47%. This is amongst the best in the industry. INSP outperforms 94.21% of its industry peers.
INSP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.81% | ||
| PM (TTM) | 6.17% | ||
| GM | 84.47% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INSP is destroying value.
INSP has more shares outstanding than it did 1 year ago.
INSP has more shares outstanding than it did 5 years ago.
INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
INSP has an Altman-Z score of 12.51. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
INSP's Altman-Z score of 12.51 is amongst the best of the industry. INSP outperforms 91.58% of its industry peers.
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 12.51 |
ROIC/WACC0.62
WACC8.66%
2.3 Liquidity
INSP has a Current Ratio of 6.14. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.14, INSP belongs to the best of the industry, outperforming 83.16% of the companies in the same industry.
INSP has a Quick Ratio of 4.84. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
INSP has a better Quick ratio (4.84) than 83.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.14 | ||
| Quick Ratio | 4.84 |
3. Growth
3.1 Past
INSP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1177.78%, which is quite impressive.
INSP shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.05%.
The Revenue has been growing by 57.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.63%
Revenue 1Y (TTM)22.05%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.82%
3.2 Future
Based on estimates for the next years, INSP will show a very strong growth in Earnings Per Share. The EPS will grow by 26.47% on average per year.
The Revenue is expected to grow by 14.74% on average over the next years. This is quite good.
EPS Next Y-70.57%
EPS Next 2Y-3.38%
EPS Next 3Y16.73%
EPS Next 5Y26.47%
Revenue Next Year13.03%
Revenue Next 2Y13.73%
Revenue Next 3Y14.05%
Revenue Next 5Y14.74%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 33.70, the valuation of INSP can be described as expensive.
Based on the Price/Earnings ratio, INSP is valued a bit cheaper than the industry average as 71.58% of the companies are valued more expensively.
INSP is valuated rather expensively when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 48.00, INSP can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 68.95% of the companies listed in the same industry.
INSP's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.7 | ||
| Fwd PE | 48 |
4.2 Price Multiples
INSP's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. INSP is cheaper than 70.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, INSP is valued cheaper than 81.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.97 | ||
| EV/EBITDA | 34.44 |
4.3 Compensation for Growth
INSP's earnings are expected to grow with 16.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.38%
EPS Next 3Y16.73%
5. Dividend
5.1 Amount
No dividends for INSP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
77.52
-2.65 (-3.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners109.56%
Inst Owner Change-0.46%
Ins Owners0.82%
Ins Owner Change0.31%
Market Cap2.29B
Revenue(TTM)861.31M
Net Income(TTM)53.12M
Analysts75.38
Price Target139.73 (80.25%)
Short Float %9.87%
Short Ratio2.66
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)127.01%
Min EPS beat(2)114.53%
Max EPS beat(2)139.49%
EPS beat(4)4
Avg EPS beat(4)247.35%
Min EPS beat(4)54.07%
Max EPS beat(4)681.29%
EPS beat(8)8
Avg EPS beat(8)257.08%
EPS beat(12)12
Avg EPS beat(12)187.32%
EPS beat(16)16
Avg EPS beat(16)150.49%
Revenue beat(2)1
Avg Revenue beat(2)0.22%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)1.13%
Revenue beat(4)2
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)-0.06%
Revenue beat(12)8
Avg Revenue beat(12)2.61%
Revenue beat(16)12
Avg Revenue beat(16)3.81%
PT rev (1m)-5.71%
PT rev (3m)-36.45%
EPS NQ rev (1m)1.73%
EPS NQ rev (3m)-135.23%
EPS NY rev (1m)1.51%
EPS NY rev (3m)-77.98%
Revenue NQ rev (1m)-0.31%
Revenue NQ rev (3m)-8.27%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-4.8%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.7 | ||
| Fwd PE | 48 | ||
| P/S | 2.66 | ||
| P/FCF | 26.97 | ||
| P/OCF | 19.52 | ||
| P/B | 3.38 | ||
| P/tB | 3.38 | ||
| EV/EBITDA | 34.44 |
EPS(TTM)2.3
EY2.97%
EPS(NY)1.61
Fwd EY2.08%
FCF(TTM)2.87
FCFY3.71%
OCF(TTM)3.97
OCFY5.12%
SpS29.13
BVpS22.92
TBVpS22.92
PEG (NY)N/A
PEG (5Y)N/A
Graham Number34.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.62% | ||
| ROE | 7.84% | ||
| ROCE | 5.84% | ||
| ROIC | 5.35% | ||
| ROICexc | 9.29% | ||
| ROICexgc | 9.29% | ||
| OM | 4.81% | ||
| PM (TTM) | 6.17% | ||
| GM | 84.47% | ||
| FCFM | 9.87% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score7
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 300.74% | ||
| Cap/Sales | 3.77% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 225.05% | ||
| Profit Quality | 160.03% | ||
| Current Ratio | 6.14 | ||
| Quick Ratio | 4.84 | ||
| Altman-Z | 12.51 |
F-Score7
WACC8.66%
ROIC/WACC0.62
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.63%
EPS Next Y-70.57%
EPS Next 2Y-3.38%
EPS Next 3Y16.73%
EPS Next 5Y26.47%
Revenue 1Y (TTM)22.05%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.82%
Revenue Next Year13.03%
Revenue Next 2Y13.73%
Revenue Next 3Y14.05%
Revenue Next 5Y14.74%
EBIT growth 1Y389.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year586.15%
EBIT Next 3Y128.27%
EBIT Next 5Y79.05%
FCF growth 1Y348.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y245.22%
OCF growth 3YN/A
OCF growth 5YN/A
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
Can you provide the ChartMill fundamental rating for INSPIRE MEDICAL SYSTEMS INC?
ChartMill assigns a fundamental rating of 6 / 10 to INSP.
What is the valuation status of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.
Can you provide the profitability details for INSPIRE MEDICAL SYSTEMS INC?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.
Can you provide the financial health for INSP stock?
The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.
What is the expected EPS growth for INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The Earnings per Share (EPS) of INSPIRE MEDICAL SYSTEMS INC (INSP) is expected to decline by -70.57% in the next year.